Drug Development

GLOBAL HEALTH 1 Credit CME Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials JAMA Network Open

CLINICAL PHARMACY AND PHARMACOLOGY 1 Credit CME Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer JAMA Oncology

LAW AND MEDICINE 21m 13s Medicaid Use and Spending for Drugs With FDA Accelerated Approval JAMA Health Forum

CRITICAL CARE MEDICINE 38m 26s 0.75 Credit CME Coronavirus Update With Peter Piot, MD, PhD JAMA

CRITICAL CARE MEDICINE 47m 41s 0.75 Credit CME Coronavirus Update With Peter Piot, MD, PhD JAMA

ADDICTION MEDICINE 21m 26s Coronavirus Update With CDC Director Rochelle Walensky JAMA

ADDICTION MEDICINE 24m 59s 0.5 Credit CME Coronavirus Update With CDC Director Rochelle Walensky, MD JAMA

HEALTH POLICY 1 Credit CME US Food and Drug Administration Support for Oncology Drug Development During COVID-19 JAMA Oncology

CORONAVIRUS (COVID-19) 1 Credit CME The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Therapy for Early COVID-19: A Critical Need JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Study Aims to Identify Drugs That Could Be Repurposed for COVID-19 JAMA

CLINICAL PHARMACY AND PHARMACOLOGY 31m 28s 0.5 Credit CME Ten Things Every New Doctor Should Know About Drug Reactions JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies JAMA Internal Medicine

CLINICAL PHARMACY AND PHARMACOLOGY 12m 50s 0.25 Credit CME Update on Dexamethasone for the Treatment of COVID-19 JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Missed Opportunities on Emergency Remdesivir Use JAMA

CLINICAL PHARMACY AND PHARMACOLOGY 36m 28s 0.5 Credit CME Remdesivir and Dexamethasone for the Treatment of COVID-19 JAMA

DRUG DEVELOPMENT 5m 46s Monoclonal Antibodies for Coronavirus JAMA

DRUG DEVELOPMENT 1 Credit CME The Equitable Distribution of COVID-19 Therapeutics and Vaccines JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times JAMA

VACCINATION 37m 56s 0.5 Credit CME The NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative JAMA